Researchers seek to improve success of chimeric antigen receptor-T cell therapy in non-Hodgkin lymphoma - Science Daily

A study investigates the reasons for decreasing remission rates for patients with non-Hodgkin lymphoma treated with chimeric antigen receptor-T cell therapy (CAR-T cell therapy).

A study published by researchers from Mayo Clinic Cancer Center at Mayo Clinic in Florida and Case Western, Cleveland Medical Center, investigates the reasons for decreasing remission rates for patie… [+2492 chars]

full article...